UNSPSC 51101687: Sulnidazole

This classification denotes an antiprotozoal agent with the molecular formula C9H14N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 504LR309YV, chemically known as r 26,412 but generally known as sulnidazole, which bears US NIH Compound Identifier 3037172. European Medicines Agency schedules Sulnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10750MIG.

UNSPSC 51101687 Sulnidazole is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement. The recent opportunities tagged to this code encompass naloxone procurement, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs—none of which are sulnidazole-specific. The code shows little relevant recent activity aligned with its nominal scope.

The mismatch suggests that state and local agencies are either using this code as a catch-all for pharmaceutical procurement broadly or that the tagging mechanism has assigned opportunities incorrectly. Prospective vendors pursuing pharmaceutical supply contracts with state health departments, counties, cities, transit authorities, and special-purpose districts should monitor broader pharmaceutical and medical-supply codes rather than rely on this Commodity code's signals. The opportunities present—such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products due March 26, 2026, Seminole County's IFB for naloxone and drug deactivation systems due July 26, 2023, the City of Tampa's ITB for medical and first aid supplies due March 13, 2026, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions due April 3, 2026—indicate active procurement across Florida, Minnesota, Texas, and other jurisdictions, but they do not cluster around sulnidazole itself.